Infliximab for Pediatric Patients With Ulcerative Colitis: A Phase 3, Open-Label, Uncontrolled, Multicenter Trial in Japan

BMC Pediatrics - United Kingdom
doi 10.1186/s12887-019-1739-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis

Gastroenterology
HepatologyGastroenterology
2018English

A Phase III, Multicenter, Collaborative, Open-Label Clinical Trial of Sildenafil in Japanese Patients With Pulmonary Arterial Hypertension

Circulation Journal
MedicineCardiovascular MedicineCardiology
2011English

A Multicenter, Open Label, Uncontrolled, Phase Ii Trial Evaluating Safety and Efficacy of Venetoclax, Atezolizumab Andobinutuzumab in Richter Transformation From CLL

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Intravenous Immunoglobulin for Maintenance Treatment of Multifocal Motor Neuropathy: A Multicenter, Open-Label, 52-Week Phase 3 Trial

Journal of the Peripheral Nervous System
MedicineNeuroscienceNeurology
2018English

Long-Term Outcomes Following Restorative Proctocolectomy Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis Patients: Multicenter National Study in Japan

Annals of Gastroenterological Surgery
2018English

A Phase I-Ii, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of 99mTc-Sestamibi in Pediatric Subjects

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

New England Journal of Medicine
Medicine
2005English

Ginger in Patients With Active Ulcerative Colitis: A Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy